AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the U.S. commercial launch of Cohealyx™, a ...

O f all the cosmetic procedures on the market right now that promise to improve visible signs of aging (and there are plenty ...

A company in the Netherlands says it has perfected a way to create "graft chimeras" with the skin of one plant and the ...

During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...

A Sparks mother is speaking out after a terrifying accident left her 8-year-old daughter with severe burns. Now, she is using ...

When he pulled up to the drive-thru at McDonald’s on U.S. 90 in Long Beach, Joseph Gentry was a “robust” 82-year-old retiree, according to a lawsuit he has filed. He drove away with “horrific” burns ...

A panelist discusses how graft-vs-host disease (GVHD) manifests through a complex constellation of symptoms affecting ...

At the Wound Center of Tucson, our goal is simple: help patients heal faster, reduce pain, and restore quality of life.

As an advocate for burn survivors and domestic violence awareness, Tonya is helping others see their own beauty and strength.

A Prince George’s County jury awarded a $35 million judgment to a woman who was hospitalized for over three months after a ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...